| NCT Number | NCT06906055 |
| Lead Sponsor | Summa Therapeutics, LLC |
| Conditions | Peripheral Arterial Disease Below the Knee, Peripheral Arterial Disease, Rutherford 4 and 5 with Possibility to Improve Vascularization |
| Enrollment | 24 participants |
| Start Date | 2025-04-03 |
| Primary Completion | 2025-12-31 (estimated) |
| Study Completion | 2026-06-30 (estimated) |
| Updated on ClinicalTrials.gov | 2025-04-02 |